Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin
- PMID: 20432254
- PMCID: PMC2908905
- DOI: 10.1002/hep.23538
Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin
Abstract
The Wnt/beta-catenin pathway is implicated in the pathogenesis of hepatocellular cancer (HCC). We developed a transgenic mouse (TG) in the FVB strain that overexpresses Ser45-mutated-beta-catenin in hepatocytes to study the effects on liver regeneration and cancer. In the two independent TG lines adult mice show elevated beta-catenin at hepatocyte membrane with no increase in the Wnt pathway targets cyclin-D1 or glutamine synthetase. However, TG hepatocytes upon culture exhibit a 2-fold increase in thymidine incorporation at day 5 (D5) when compared to hepatocytes from wildtype FVB mice (WT). When subjected to partial hepatectomy (PH), dramatic increases in the number of hepatocytes in S-phase are evident in TG at 40 and WT at 72 hours. Coincident with the earlier onset of proliferation, we observed nuclear translocation of beta-catenin along with an increase in total and nuclear cyclin-D1 protein at 40 hours in TG livers. To test if stimulation of beta-catenin induces regeneration, we used hydrodynamic delivery of Wnt-1 naked DNA to control mice, which prompted an increase in Wnt-1, beta-catenin, and known targets, glutamine synthetase (GS) and cyclin-D1, along with a concomitant increase in cell proliferation. beta-Catenin-overexpressing TG mice, when followed up to 12 months, showed no signs of spontaneous tumorigenesis. However, intraperitoneal delivery of diethylnitrosamine (DEN), a known carcinogen, induced HCC at 6 months in TG mice only. Tumors in TG livers showed up-regulation of beta-catenin, cyclin-D1, and unique genetic aberrations, whereas other canonical targets were unremarkable.
Conclusion: beta-Catenin overexpression offers growth advantage during liver regeneration. Also, whereas no spontaneous HCC is evident, beta-catenin overexpression makes TG mice susceptible to DEN-induced HCC.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2908905/bin/nihms221284f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2908905/bin/nihms221284f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2908905/bin/nihms221284f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2908905/bin/nihms221284f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2908905/bin/nihms221284f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2908905/bin/nihms221284f6.gif)
Similar articles
-
Wnt/-Catenin Signaling and Liver Regeneration: Circuit, Biology, and Opportunities.Gene Expr. 2021 Jun 11;20(3):189-199. doi: 10.3727/105221621X16111780348794. Epub 2021 Jan 20. Gene Expr. 2021. PMID: 33472727 Free PMC article. Review.
-
Alcohol consumption, Wnt/β-catenin signaling, and hepatocarcinogenesis.Adv Exp Med Biol. 2015;815:185-95. doi: 10.1007/978-3-319-09614-8_11. Adv Exp Med Biol. 2015. PMID: 25427908 Free PMC article. Review.
-
β-catenin signaling in murine liver zonation and regeneration: a Wnt-Wnt situation!Hepatology. 2014 Sep;60(3):964-76. doi: 10.1002/hep.27082. Epub 2014 Jul 25. Hepatology. 2014. PMID: 24700412 Free PMC article.
-
β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.PLoS One. 2012;7(6):e39771. doi: 10.1371/journal.pone.0039771. Epub 2012 Jun 25. PLoS One. 2012. PMID: 22761897 Free PMC article.
-
Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.J Hepatol. 2011 Mar;54(3):506-12. doi: 10.1016/j.jhep.2010.07.020. Epub 2010 Oct 29. J Hepatol. 2011. PMID: 21093092 Free PMC article.
Cited by
-
Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target.Front Oncol. 2024 Apr 2;14:1367364. doi: 10.3389/fonc.2024.1367364. eCollection 2024. Front Oncol. 2024. PMID: 38634048 Free PMC article. Review.
-
Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing.Hepatol Commun. 2024 Mar 18;8(4):e0412. doi: 10.1097/HC9.0000000000000412. eCollection 2024 Apr 1. Hepatol Commun. 2024. PMID: 38497929 Free PMC article.
-
Wnt-β-catenin in hepatobiliary homeostasis, injury, and repair.Hepatology. 2023 Dec 1;78(6):1907-1921. doi: 10.1097/HEP.0000000000000495. Epub 2023 May 30. Hepatology. 2023. PMID: 37246413 Review.
-
Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling.Clin Epigenetics. 2022 Dec 2;14(1):164. doi: 10.1186/s13148-022-01388-3. Clin Epigenetics. 2022. PMID: 36461092 Free PMC article.
-
Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis.Front Oncol. 2022 Oct 5;12:958696. doi: 10.3389/fonc.2022.958696. eCollection 2022. Front Oncol. 2022. PMID: 36276076 Free PMC article. Review.
References
-
- Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology. 2007;45:1298–1305. - PubMed
-
- Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, Vasseur-Cognet M, et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell. 2006;10:759–770. - PubMed
-
- Orsulic S, Huber O, Aberle H, Arnold S, Kemler R. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci. 1999;112(Pt 8):1237–1245. - PubMed
-
- Sekine S, Gutierrez PJ, Lan BY, Feng S, Hebrok M. Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology. 2007;45:361–368. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous